
HomeSpecialty IngredientOmegablue® by Indena S.p.A.
Omegablue® by Indena S.p.A.
Omegablue® by Indena S.p.A.
Omegablue® is a bilberry seed oil extract rich in omega-3 polyunsaturated fatty acids, including alpha-linolenic acid (ALA) and linoleic acid (LA). It supports cardiovascular health by maintaining normal blood cholesterol levels. Omegablue® is Non-GMO, solvent-free, and suitable for softgels and liquid formulations. Manufactured under GMP standards, it is commonly used in heart health and lipid management supplements.
0
0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Technology:
Name:
Omegablue®
Ingredient/s:
Categories:
Heart Health, Antioxidant, General Health
Dosage (min):
Dosage (max):
1000 mg
MOQ:
Price kg:
Botanicals:
Vaccinium myrtillus (fruit)
Active/s:
Omega-3 fatty acids, Anthocyanins
Assay:
Standardized to 36% anthocyanins
Country of Origin:
Suppliers:
Indena S.p.A
Contact Information
Email:
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Ingredient Highlights
Omegablue® features clinically supported actives shown to help:
Ingredient Overview
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Ingredient Highlights
Omegablue® features clinically supported actives shown to help:
- Support cardiovascular health and lipid balance.
- Promote antioxidant activity from marine polyphenols.
- Support reduced oxidative stress in heart tissues.
- Aid healthy blood flow and circulation.
- Enhance omega-3 bioactivity and synergy.
- Support vascular tone and endothelial function.
- Promote metabolic wellness and anti-inflammatory balance.*
Global Regulatory Market Access Status - Coming Soon
Science & Research - Coming Soon
Featured Content
Product type
Endorsement
0
0 out of 5 stars (based on 0 endorsements)
Excellent
Very good
Average
Poor
Terrible
There are no reviews yet. Be the first one to write one.








